| 发明名称 |
FORMS A AND B OF N-[[[2-[[[2-[(DIAMINOMETHYLENE)AMINO]-4-THIAZOLYL]METHYL]THIO]ETHYL]AMINO]METHYLENE]-4-BROMO-BENZENESULFONAMIDE |
| 摘要 |
Ebrotidine is indicated for the treatment of duodenal ulceration, benign gastric or pre-pyloric peptic ulcer, and nonsteroidal anti-inflammatory drug-induced gastroduodenal lesions. Ebrotidine in combination with antibiotics is used for the eradication of Helicobacter pylori in duodenal ulcer patients.
|
| 申请公布号 |
CA2180378(A1) |
申请公布日期 |
1996.05.17 |
| 申请号 |
CA19942180378 |
申请日期 |
1994.11.04 |
| 申请人 |
FERRER INTERNACIONAL, S.A. |
发明人 |
FOGUET AMBROS, RAFAEL;ANGLADA BURNIOL, LLUIS;ORTIZ HERNANDEZ, JOSE A.;SACRISTAN MUNOZ, AURELIO;CASTELLO BARENYS, JOSEP MARIA |
| 分类号 |
C07D277/20;A61K31/425;A61K31/426;A61P43/00;C07D277/42;C07D277/48;(IPC1-7):C07D277/48 |
主分类号 |
C07D277/20 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
